The effect of Different Warmer’s Temperature on Core Temperature and Bleeding Rate in Patients Undergoing Posterior Spinal Fusion Surgery in Tehran Pars Hospital

The effect of Different Warmer’s Temperature on Core Temperature and Bleeding Rate in Patients Undergoing Posterior Spinal Fusion Surgery in Tehran Pars Hospital: Randomization Clinical Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141225020434N2

Enrollment

Registered

2017-12-20

Start date

2017-04-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing posterior spinal fusion surgery. Other specified degenerative disorders of nervous system in diseases classified elsewhere

Interventions

Intervention 1: The warmer will set at 40oC for the intervention group during surgery. The anesthesia protocol for both groups will consist of premedication with 0.05 mg/kg midazolam, induction by 5 m

Prevention

The warmer will set at 40oC for the intervention group during surgery. The anesthesia protocol for both groups will consist of premedication with 0.05 mg/kg midazolam, induction by 5 mg/kg thiopental

Comparison group: The temperature in this group is 38 ° C

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients candidates for posterior spinal fusion surgery

Exclusion criteria

Exclusion criteria: Ischemic Heart Disease Diabetic Patients Kidney Disease Hypertension Infection Disease Sepsis Coagulation Disorders

Design outcomes

Primary

Measure	Time frame
Core temperature. Timepoint: Before, during and after surgery. Method of measurement: Thermometer.;Heart rate. Timepoint: Before, during and after surgery. Method of measurement: Monitor Vital Signs.;Respiratory rate. Timepoint: Before, during and after surgery. Method of measurement: Monitor Vital Signs.;Arterial blood pressure. Timepoint: Before, during and after surgery. Method of measurement: Monitor Vital Signs.;Hemoglobin. Timepoint: Before, during and after surgery. Method of measurement: Blood sample.;Hematocrit and platelet. Timepoint: Before, during and after surgery. Method of measurement: Blood sample.	—

Measure

Time frame

Core temperature. Timepoint: Before, during and after surgery. Method of measurement: Thermometer.;Heart rate. Timepoint: Before, during and after surgery. Method of measurement: Monitor Vital Signs.;Respiratory rate. Timepoint: Before, during and after surgery. Method of measurement: Monitor Vital Signs.;Arterial blood pressure. Timepoint: Before, during and after surgery. Method of measurement: Monitor Vital Signs.;Hemoglobin. Timepoint: Before, during and after surgery. Method of measurement: Blood sample.;Hematocrit and platelet. Timepoint: Before, during and after surgery. Method of measurement: Blood sample.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Valiolla Hasani

Iran University of Medical Sciences

Hassani.v@iums.ac.ir+98 21 6435 2107

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026